Search hospitals
>
New York
>
New York
Laura and Isaac Perlmutter Cancer Center at NYU Langone
Claim this profile
New York, New York 10016
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Solid Tumors
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
354 reported clinical trials
47 medical researchers
Summary
Laura and Isaac Perlmutter Cancer Center at NYU Langone is a medical facility located in New York, New York. This center is recognized for care of Cancer, Lung Cancer, Solid Tumors, Breast Cancer, Pancreatic Cancer and other specialties. Laura and Isaac Perlmutter Cancer Center at NYU Langone is involved with conducting 354 clinical trials across 640 conditions. There are 47 research doctors associated with this hospital, such as Sharon L. Gardner, Bhavana Pothuri, Paul Oberstein, MD, and Vamsidhar Velcheti, MD.
Area of expertise
Cancer
Laura and Isaac Perlmutter Cancer Center at NYU Langone has run 81 trials for Cancer. Some of their research focus areas include:
Lung Cancer
Laura and Isaac Perlmutter Cancer Center at NYU Langone has run 55 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Sharon L. Gardner
Laura and Isaac Perlmutter Cancer Center at NYU Langone
8 years of reported clinical research
Bhavana Pothuri
Laura and Isaac Perlmutter Cancer Center at NYU Langone
2 years of reported clinical research
Paul Oberstein, MD
NYU Langone Health
4 years of reported clinical research
Vamsidhar Velcheti, MD
Laura and Isaac Perlmutter Cancer Center at NYU Langone
2 years of reported clinical research
Clinical Trials running at Laura and Isaac Perlmutter Cancer Center at NYU Langone
Lung Cancer
Bladder Cancer
Breast Cancer
Skin Cancer
Cancer
Breast cancer
Ovarian Cancer
Kidney Cancer
Pancreatic Cancer
Brain Tumor
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Proton Craniospinal Radiation
for Cancer in the Brain and Spinal Cord
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting
2 awards
Phase 3
3 criteria
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting
2 awards
Phase 3
7 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Laura and Isaac Perlmutter Cancer Center at NYU Langone?
Laura and Isaac Perlmutter Cancer Center at NYU Langone is a medical facility located in New York, New York. This center is recognized for care of Cancer, Lung Cancer, Solid Tumors, Breast Cancer, Pancreatic Cancer and other specialties. Laura and Isaac Perlmutter Cancer Center at NYU Langone is involved with conducting 354 clinical trials across 640 conditions. There are 47 research doctors associated with this hospital, such as Sharon L. Gardner, Bhavana Pothuri, Paul Oberstein, MD, and Vamsidhar Velcheti, MD.
Where is Laura and Isaac Perlmutter Cancer Center at NYU Langone located?
**Laura and Isaac Perlmutter Cancer Center at NYU Langone Health** - **Address:** 160 East 34th Street, New York, NY 10016 - **Designation:** National Cancer Institute-designated Comprehensive Cancer Center - **Focus:** Cutting-edge research, patient care, and community outreach.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Laura and Isaac Perlmutter Cancer Center at NYU Langone, contact the Financial Counselors and Financial Assistance for Hospital Bills department at 718-630-7136. They assist with applications, insurance coverage, and billing concerns for uninsured patients or those with partial insurance coverage. For financial aid related to medical education at NYU Langone Health, reach out to the Office of Admissions and Financial Aid via finaid@nyulangone.org or at 212-263-5286. They manage financial aid for MD students, offering information on scholarships, loans, and other resources.
What insurance does Laura and Isaac Perlmutter Cancer Center at NYU Langone accept?
The Laura and Isaac Perlmutter Cancer Center at NYU Langone accepts various insurance plans. Patients are advised to consult the list of insurance plans NYU Langone participates in to verify coverage and should also check with their doctors to confirm participation in their insurance plan's network. The Perlmutter Cancer Center operates in Manhattan, Brooklyn, Queens, and Long Island; patients should confirm insurance acceptance with their specific facility.
What awards or recognition has Laura and Isaac Perlmutter Cancer Center at NYU Langone received?
The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, an NCI-Designated Comprehensive Cancer Center, excels in basic science and clinical research, cancer prevention, and the education of researchers and clinicians. It has received a 51% increase in NCI funding, totaling nearly $20 million, and a generous $50 million gift from Laura and Isaac Perlmutter to enhance its research and care efforts. The center's research focuses on cancer cell biology, cancer genome dynamics, tumor immunology, melanoma, and epidemiology and cancer control, promoting translational research and multidisciplinary care.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.